Properties
Description
Licogliflozin is a sodium-glucose cotransporter inhibitor, preventing the kidneys from reabsorbing glucose.
Molecular Formula
C23H28O7
Identity
Confirmed by NMR/HPLC/MS.
Applications
Licogliflozin, an SGLT inhibitor, is studied for its potential impact on metabolic disorders and diabetes management.